Product News and Recalls

Zostavax Competitor Wins Unanimous Recommendation for Approval

shingrix wins approval recommendationAfter considering the data, every member of an FDA advisory panel convened this month voted to recommend the approval of Shingrix – a new shingles vaccine developed and marketed by GlaxoSmithKline.

Data was not based solely on efficacy, or effectiveness. Rather, the data also took the vaccine’s safety into consideration. Panel members were “very impressed” with that data on both fronts and – according to Reuters – believe that Shingrix is ...

continue reading...

Forbes Analysis: Danger Warnings Make Invokana Harder to Sell

investors weary of invokanaThe analysis is in: people are less likely to buy a medication when they’ve been warned that it may increase the odds of them having their leg or foot amputated. And, while this is bad news for Invokana specifically, Forbes would like you to know that Johnson & Johnson – the drug’s manufacturer – will be just fine.

This is the gist of an article that appeared on the Forbes website ...

continue reading...

New Research Shows High Degree of Overuse of IVC Filters in United States

ivc filters overused in united statesNew research has emerged detailing what appears to be a significant over-reliance on IVC filters by the medical community in the United States. The study was led by Dr. Riyaz Bashir of Temple University and Temple University Hospital, and found that more than one million IVC filters had been placed in patients over a ten year period.

That total accounts for an increase of IVC filter implants of roughly ...

continue reading...

Tort Lawsuits on the Decline as Factors Converge

tort lawsuits on the declineIt should surprise no one that the United States has had a reputation as one of the most litigious countries in the world for a very long time. And according to an article recently published in the Wall Street Journal, even though it may still seem that way, the reality is that this reputation may be less deserved now than at any point in recent history. In fact, less ...

continue reading...

Opana ER Pulled from Shelves Over Abuse Concerns

sales of opana halted by FDAEndo Pharmaceuticals has officially withdrawn Opana ER from the market at the FDA’s request. The extended release opioid medication recently became the subject of an inquiry by the agency because of the specific way it was being abused.

Opana ER was designed to slowly and steadily medicate a patient as an extended release medication. However, when crushed, snorted, or injected, an abuser can get the full dose in a ...

continue reading...

Hernia Patients Over-Prescribed Opioids for Recovery

 hernia patients over-prescribed opioidsA new study published in the journal Surgery has found that patients recovering from hernia procedures may require far fewer opioids to manage their pain than they are often prescribed. Some data indicates that patients are frequently given up to 30 pills after such procedures, the majority of which are unnecessary and could lead to them becoming addicted to opioids.

The study, helmed by Dr. Peter Masiakos of Massachusetts General ...

continue reading...
Page 5 of 309 «...34567...»